EcoDrugPlus

Somatostatin Receptor 5

Ensembl ID : ENSOSIG00000011515
Gene Symbol: SSTR5
1 Cross references
188 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2b

Ensembl ID : ENSOSIG00000019333
Gene Symbol: SRD5A2B
1 Cross references
191 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSOSIG00000015943
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSOSIG00000018291
Gene Symbol: TACR1
1 Cross references
194 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSOSIG00000011310
Gene Symbol: TACR2
1 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSOSIG00000011949
Gene Symbol: TACR3
1 Cross references
208 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSOSIG00000011540
Gene Symbol: TACR3L
1 Cross references
218 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSOSIG00000012893
Gene Symbol: TYMS
1 Cross references
224 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSOSIG00000007232
Gene Symbol: TRHR
1 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSOSIG00000009198
Gene Symbol: TRHRB
1 Cross references
193 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSOSIG00000013580
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSOSIG00000013590
Gene Symbol: TLR8
1 Cross references
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).